Long-term results of cornea collagen cross-linking with riboflavin for keratoconus

Autor: Vinay Agrawal
Jazyk: angličtina
Rok vydání: 2013
Předmět:
Epidemiology
keratoconus
prevalence
Disease pathogenesis
genetic heterogeneity
genetics and genomics
genome-wide association study
genomic loci
linkage mapping
molecular mechanisms
whole exome-genome sequencing
Deregulation
ectasia
gene expression
mass spectroscopy
proteomics
signaling pathways
Cornea
crosslinking
modulus
Corneal topography
imaging
optical coherence tomography
placido disc based topography
Ectatic disease
scheimpflug imaging
Keratoconus
ocular allergy
vernal keratoconjunctivitis
Contact lens
piggy back contact lenses
rigid gas permeable
scleral lens
SynergEyes
toric soft contact lens
Corneal cross-linking techniques
new technologies
riboflavin
Collagen cross linking
Corneal collagen cross-linking
hypoosmolar riboflavin
thin cornea
transepithelial collagen cross-linking
Corneal cross-linking
radiant exposure
ultraviolet-A
Accelerated corneal cross linking
corneal laser surgery
corneal ectasia
UV light
Laser in situ keratomileusis surgery
very high fluence collagen cross-linking
corneal ectosia
LASIK ectosia prophylaxis
Cornea collagen cross linking
long term results
Ophthalmology
RE1-994
Zdroj: Indian Journal of Ophthalmology, Vol 61, Iss 8, Pp 433-434 (2013)
Druh dokumentu: article
ISSN: 0301-4738
1998-3689
DOI: 10.4103/0301-4738.116072
Popis: Corneal collagen cross-linking with riboflavin and UVA light (CXL) is the only method designed to arrest the progression of keratoconus. Visual improvement generally starts 3 months after treatment. Reduction is coma seen on aberrometry in early postoperative phase is also responsible for the improvement in visual acuity. In the light of currently available data we can thus say that CXL is a safe procedure that is successful in arresting keratoconus.
Databáze: Directory of Open Access Journals
Externí odkaz: